Kimberly-Clark to acquire Kenvue, owner of Band-Aid and Neutrogena, in a $48.7 billion deal

361

In one of the biggest consumer goods deals of the decade, Kimberly-Clark will acquire Kenvue, the company behind household names like Band-Aid, Neutrogena, Tylenol, and Listerine, for $48.7 billion. The acquisition marks Kimberly-Clark’s largest-ever purchase and positions it as a major force in the global health and wellness category. 

The merger will bring together two powerful portfolios — Kimberly-Clark’s hygiene and baby care products, including Huggies, Kleenex, and Kotex, with Kenvue’s trusted consumer health brands. Analysts say the move aims to strengthen Kimberly-Clark’s long-term growth in personal care, skin health, and over-the-counter wellness.

Executives from both companies described the deal as “transformational,” citing the potential for innovation, brand synergies, and expanded reach across mature and emerging markets. The acquisition also reflects a growing trend of convergence between consumer goods and healthcare companies, driven by shifting consumer priorities toward health, hygiene, and well-being.

Kenvue, which went public in 2023 after its spin-off from Johnson & Johnson, reported over $15 billion in annual revenue. Kimberly-Clark’s acquisition will integrate Kenvue’s R&D and digital commerce capabilities into its global network, creating what analysts call a consumer health powerhouse.

The deal is expected to close by mid-2026, subject to regulatory approvals.